Blog is a section where we post our product related story and news about our product related update and news. You will be finding here all oncology products update and information of disease that are related to oncology.
For those of us managing NTRK fusion cancers, the shift from treating a lung or colon tumor to treating a molecular driver has fundamentally changed how we practice oncology. We’ve officially moved past the honeymoon phase of targeted therapy. Today,…
Accessing the latest targeted cancer therapies is one of the greatest challenges in modern healthcare. As the FDA approves breakthrough treatments, the cost often skyrockets, leaving many patients behind. However, a solution has emerged in the global market: the rise…
Product Profile: Olanib 150 mg (Everest Pharmaceuticals Ltd.) Olanib 150 mg serves as a cornerstone in the portfolio of Everest Pharmaceuticals Ltd., specifically targeting the growing need for accessible precision oncology solutions. Formulation and Dosage Form Olanib is formulated as…
Managing Hematological Toxicity: Anemia and Neutropenia Hematological adverse events are among the most common reasons for dose modifications in Olaparib therapy. The mechanism involves the suppression of rapidly dividing hematopoietic progenitor cells in the bone marrow. Anemia (Low Red Blood…
The Evolution of Targeted Oncology and the Generic Imperative The trajectory of modern oncology has shifted decisively from the era of indiscriminate cytotoxic chemotherapy toward the precision of molecularly targeted agents. At the forefront of this revolution is the inhibition…
Targeted therapy is different from chemotherapy. Instead of killing cells instantly, Gilteritinib forces leukemia cells to “mature” (differentiate) into normal cells. Sometimes, this process releases a flood of immune substances (cytokines) into the body, leading to a condition called Differentiation…
For many AML patients, the cost of maintenance therapy is the biggest barrier to health. When doctors prescribe Gilteritinib (brand name Xospata®), the price tag can be shocking. Regulatory Standards High-quality generics are approved by regulatory bodies (like the FDA…
Receiving a diagnosis of Acute Myeloid Leukemia (AML) is overwhelming. But hearing that your AML is “FLT3-positive” adds another layer of complexity. For decades, the standard treatment for AML remained unchanged. However, the discovery of the FLT3 mutation—and the subsequent…
Early Morning Routine Routine Benefits: for everyday-life is very important for your health, wealth along with physical and mental health
There are 10 such signs that can assure you that you have lung cancer. Know what are those signs.
